One Pager as on September 30, 2026
![]() | Agile quality portfolio from India's Big 100 Companies* |
![]() | Exposure to the more stable half of the market |
![]() | High conviction bottom up stock picking with a focus on alpha generation |
| *In terms of Full Market Capitalisation. |
| Sector | MMLCF* | Nifty 100 TRI |
| Financial Services | 33.63% | 33.70% |
| Automobile And Auto Components | 8.21% | 7.24% |
| Consumer Services | 6.60% | 2.95% |
| Healthcare | 6.55% | 5.53% |
| Information Technology | 6.04% | 6.72% |
*Mahindra Manulife Large Cap Fund
Data as on September 30, 2026
| Security | % to Net Assets |
| ICICI Bank Limited | 8.79% |
| HDFC Bank Limited | 8.06% |
| Reliance Industries Limited | 4.97% |
| Bharti Airtel Limited | 4.45% |
| Axis Bank Limited | 3.60% |
| Larsen & Toubro Limited | 3.47% |
| Eternal Limited | 3.22% |
| TVS Motor Company Limited | 2.61% |
| Bajaj Finserv Limited | 2.60% |
| Infosys Limited | 2.59% |
| Total | 44.36% |
| Fresh Additions | Complete Exits |
| Security | Security |
| Multi Commodity Exchange of India Limited | Tata Capital Limited |
| LG Electronics India Ltd | Punjab National Bank |
| Nippon Life India Asset Management Limited | Havells India Limited |
| HDB Financial Services Limited | |
| Indus Towers Limited | |
| Max Healthcare Institute Limited |
Note:
The companies/stock(s) referred above are only for the purpose of disclosure of significant
portfolio changes during the month and should not be construed as recommendation to buy/sell/
hold. The fund manager may or may not choose to hold these companies/stocks, from time to
time. Investors are requested to consult their financial, tax and other advisors before taking any
investment decision(s). Data as on September 30, 2026
| Turnover Ratio (Last 1 year) | 0.66 |
| Standard Deviation | 14.36% |
| Beta | 0.95 |
| Sharpe Ratio# | 0.04 |
| Jenson's Alpha | -0.1629 |
#Risk-free rate assumed to be 5.07% (MIBOR as on 30-09-2026) - Source: www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling
returns for last 3 years. Data as on September 30, 2026
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Ms. Kirti Dalvi is managing this scheme since December 02, 2025 and Mr. Hemang Kapasi is managing this scheme since September 25, 2026. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. $Note Pursuant to notice cum addendum no. 42/2026, Fund Manager of the scheme has been changed with effect from September 25, 2026.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Ms. Kirti Dalvi manages 7 schemes and Mr. Hemang Kapasi manages 4 schemes
of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Note: The performance data of Mahindra Manulife Innovation Opportunities Fund has not been provided as the scheme has not completed 1 year since inception. The said Scheme is managed by
Ms. Kirti Dalvi.
$Note: Pursuant to notice cum addendum no. 42/2026, Fund Manager of the scheme has been changed with effect from September 25, 2026.
Note: Performance as on September 30, 2026.
This product is suitable for investors who are seeking*:
• Long term capital appreciation;
• Investment predominantly in equity and equity related securities including derivatives of large cap companies.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
![]() |
||||
![]() |
![]() |
![]() |
![]() |
![]() |